Hybrid nanovaccine for the co-delivery of the mRNA antigen and adjuvant

Nanoscale ◽  
2019 ◽  
Vol 11 (45) ◽  
pp. 21782-21789 ◽  
Author(s):  
Jingnan Yang ◽  
Smriti Arya ◽  
Pingsai Lung ◽  
Qiubin Lin ◽  
Jiandong Huang ◽  
...  
Keyword(s):  
T Cells ◽  
Cancer Therapy ◽  
Cancer Vaccines ◽  
Cytotoxic T Cells ◽  
Personalized Cancer Therapy ◽  
Personalized Cancer

For efficient cancer vaccines, the antitumor function largely relies on cytotoxic T cells, whose activation can be effectively induced via antigen-encoding mRNA, making mRNA-based cancer vaccines an attractive approach for personalized cancer therapy.

scholarly journals 3D Bioprinted cancer models: Revolutionizing personalized cancer therapy

2021 ◽  
Vol 14 (4) ◽  
pp. 101015
Author(s):  
Robin Augustine ◽  
Sumama Nuthana Kalva ◽  
Rashid Ahmad ◽  
Alap Ali Zahid ◽  
Shajia Hasan ◽  
...  
Keyword(s):  
Cancer Therapy ◽  
Cancer Models ◽  
Personalized Cancer Therapy ◽  
Personalized Cancer

Imaging of TKI–Target Interactions for Personalized Cancer Therapy

2012 ◽  
Vol 93 (3) ◽  
pp. 239-241 ◽  
Author(s):  
A J Poot ◽  
P Slobbe ◽  
N H Hendrikse ◽  
A D Windhorst ◽  
GAMS van Dongen
Keyword(s):  
Cancer Therapy ◽  
Personalized Cancer Therapy ◽  
Personalized Cancer

Sequencing Approaches for Personalized Cancer Therapy Selection in Pathology

2019 ◽  
pp. 432-438
Author(s):  
Wendy de Leng ◽  
Manon Huibers ◽  
John Hinrichs ◽  
Edwin Cuppen ◽  
Stefan Willems
Keyword(s):  
Cancer Therapy ◽  
Personalized Cancer Therapy ◽  
Personalized Cancer

Availability of pharmacogenetic and pharmacogenomic information in anticancer drug monographs in France: personalized cancer therapy

2011 ◽  
Vol 12 (5) ◽  
pp. 681-691 ◽  
Author(s):  
Laetitia Albertini ◽  
Gérard Siest ◽  
Elise Jeannesson ◽  
Sophie Visvikis-Siest
Keyword(s):  
Cancer Therapy ◽  
Anticancer Drug ◽  
Personalized Cancer Therapy ◽  
Personalized Cancer
Sign in / Sign up

Export Citation Format

Share Document